Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study
British Journal of Haematology · 2026-03 · 208 (3) · 897-904
DOI: 10.1111/bjh.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 19.12.2025. Verfasst von Augustin Boudry und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hematology, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Fertility Preservation, Ovary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GIP Cancéropôle Nord-Ouest.
Abstract (Originalsprache)
Allogeneic haematopoietic stem cell transplantation (ASCT) is a curative treatment for acute myeloid leukaemia (AML) but carries a high risk of gonadotoxicity. Ovarian tissue cryopreservation (OTC) offers a fertility preservation option, yet its safety in AML remains uncertain due to the risk of leukaemic cell reintroduction. The FERTILAM pilot study evaluated measurable residual disease (MRD) in ovarian tissue collected at complete remission (CR) from nine AML patients undergoing OTC before ASCT. MRD was assessed using patient‐specific clonal markers via droplet digital polymerase chain reaction on DNA and RNA from bone marrow (BM), ovarian cortex and medulla. At CR, MRD‐DNA was detected in ovarian cortex of four of nine patients, all with concurrent MRD positivity in BM. Three patients were negative in both BM and ovarian tissue. Paired cortex/medulla analyses showed concordant MRD‐DNA results in five of six patients. BM MRD‐RNA and MRD‐DNA were fully concordant, whereas two discrepancies were observed between MRD‐DNA and MRD‐RNA in ovarian tissue. These findings suggest potential leukaemic cell persistence in ovarian tissue despite CR and highlight the need for sensitive molecular assays to assess safety prior to ovarian tissue transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Hematology, CHU Lille, Lille, France.
- Université de Lille, CHU de Lille, ULR 2694-METRICS, Lille, France.
- Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
- Cancer Heterogeneity Plasticity and Resistance to Therapies (CANTHER), UMR9020-U1277, University of Lille, Lille, France.
- Department of Hematology, Université Paris Nord, Hôpital Avicenne, AP-HP, Bobigny, France.
- Research Unit EA-3518, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
ORCID-Profile: Catherine Poirot, Laurène Fenwarth
Förderung
- GIP Cancéropôle Nord-Ouest
Zitieren
APA
Boudry, A., Chevillon, F., Marceau-Renaut, A., Braun, T., Boyer, T., Helevaut, N., Fournier, E., Geffroy, S., Boissel, N., Clappier, E., Preudhomme, C., Duployez, N., Poirot, C., & Fenwarth, L. (2026). Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study. British Journal of Haematology, 208(3), 897-904. https://doi.org/10.1111/bjh.70289
Vancouver
Boudry A, Chevillon F, Marceau-Renaut A, Braun T, Boyer T, Helevaut N, et al. Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study. British Journal of Haematology. 2026;208(3):897-904. doi:10.1111/bjh.70289
BibTeX
@article{Boudry2026,
author = {Boudry, Augustin and Chevillon, Florian and Marceau-Renaut, Alice and Braun, Thorsten and Boyer, Thomas and Helevaut, Nathalie and Fournier, Elise and Geffroy, Sandrine and Boissel, Nicolas and Clappier, Emmanuelle and Preudhomme, Claude and Duployez, Nicolas and Poirot, Catherine and Fenwarth, Laurène},
title = {Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {3},
pages = {897--904},
doi = {10.1111/bjh.70289}
}
EUVIMED